PRODISC -L TOTAL DISC REPLACEMENT DEVICE

Prosthesis, Intervertebral Disc

FDA Premarket Approval P050010

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the prodisc-l total disc replacement. The device is indicated for spinal arthroplasty in skeletally mature patients with degenerative disc disease (ddd) at one level from l3-s1. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These ddd patients should have no more than grade 1 spondylolisthesis at the involved level. Patients receiving the prodisc-l total disc replacement should have failed at least six months of conservative treatment prior to implantation of the prodisc-l total disc replacement.

DevicePRODISC -L TOTAL DISC REPLACEMENT DEVICE
Classification NameProsthesis, Intervertebral Disc
Generic NameProsthesis, Intervertebral Disc
ApplicantCentinel Spine, LLC
Date Received2005-03-15
Decision Date2006-08-14
Notice Date2006-08-25
PMAP050010
SupplementS
Product CodeMJO
Docket Number06M-0343
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address Centinel Spine, LLC 900 Airport Road, Suite 3b west Chester, PA 19380
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050010Original Filing
S023 2021-03-01 30-day Notice
S022 2019-09-09 Real-time Process
S021
S020
S019 2017-10-18 30-day Notice
S018
S017 2016-01-15 30-day Notice
S016 2014-04-03 135 Review Track For 30-day Notice
S015
S014 2012-12-07 Normal 180 Day Track
S013 2012-11-08 Normal 180 Day Track No User Fee
S012 2011-04-26 Real-time Process
S011 2011-01-28 135 Review Track For 30-day Notice
S010 2010-09-29 135 Review Track For 30-day Notice
S009 2010-09-15 135 Review Track For 30-day Notice
S008 2010-08-02 Real-time Process
S007 2010-05-19 Normal 180 Day Track No User Fee
S006 2010-04-26 30-day Notice
S005 2010-04-26 30-day Notice
S004
S003 2008-07-28 30-day Notice
S002 2008-05-29 135 Review Track For 30-day Notice
S001 2007-12-26 Real-time Process

NIH GUDID Devices

Device IDPMASupp
10705034700182 P050010 000
H981PDLMIP00S0D P050010 000
H981PDLLSP11S0O P050010 000
H981PDLLSP06S0S P050010 000
H981PDLLPT14S0S P050010 000
H981PDLLPT12S0Q P050010 000
H981PDLLPT10S0O P050010 000
H981PDLLIP00S0C P050010 000
00843193114983 P050010 000
00843193114976 P050010 000
00843193114969 P050010 000
00843193114952 P050010 000
00843193114945 P050010 000
00843193114938 P050010 000
H981PDLMPT10S0P P050010 000
H981PDLMPT12S0R P050010 000
10705034700175 P050010 000
10705034700151 P050010 000
10705034700144 P050010 000
10705034700137 P050010 000
10705034700106 P050010 000
10705034700090 P050010 000
10705034700083 P050010 000
10705034700069 P050010 000
10705034700052 P050010 000
10705034700045 P050010 000
H981PDLMSP11S0P P050010 000
H981PDLMSP06S0T P050010 000
H981PDLMPT14S0T P050010 000
00843193111692 P050010 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.